Eric Prinssen

3.8k citations

60 papers · 2.8k indexed · 1 hit paper · h-index 25

Impact in

Biological Psychiatry top 1%
- Tryptophan and brain disorders
Behavioral Neuroscience top 2%
- Stress Responses and Cortisol

Papers in ⓘ

Biological Psychiatry 7
- Tryptophan and brain disorders 7
Cellular and Molecular Neuroscience 38
- Neurotransmitter Receptor Influence on Behavior 16
- Neuroscience and Neuropharmacology Research 15
- Neuropeptides and Animal Physiology 11

Co-authors: Laurent B. Nicolas (5 shared papers)Stephen Toovey (5 shared papers)Irène Knuesel (2 shared papers)Markus Britschgi (2 shared papers)Scott Schobel (1 shared paper)Michael Bodmer (1 shared paper)Jessica A. Hellings (1 shared paper)Laurie Chicha (1 shared paper)
Journals: European Journal of Pharmacology (11 papers)Psychopharmacology (8 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Basic & Clinical Pharmacology & Toxicology (3 papers)Journal of Pharmacology and Experimental Therapeutics (3 papers)
Partner nations: Switzerland United States France

In The Last Decade

Eric Prinssen

59 papers receiving 2.8k citations

Hit Papers

align trajectories log scale

Maternal immune activation and abnormal brain development across CNS disorders 2014 · 631 citations

Peers

Countries citing papers authored by Eric Prinssen

Since Specialization

Citations

This map shows the geographic impact of Eric Prinssen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Prinssen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Prinssen more than expected).

Fields of papers citing papers by Eric Prinssen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Prinssen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Prinssen. The network helps show where Eric Prinssen may publish in the future.

Co-authors

The 25 scholars most cited alongside Eric Prinssen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eric Prinssen Line = papers co-authored together Eric Prinssen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Maternal immune activation and abnormal brain development across CNS disorders Nature Reviews Neurology ·Irène Knuesel, Laurie Chicha, Markus Britschgi, Scott Schobel, Michael Bodmer, Jessica A. Hellings, Stephen Toovey, Eric Prinssen Hit paper breakdown →	2014	631
2	Fenobam: A Clinically Validated Nonbenzodiazepine Anxiolytic Is a Potent, Selective, and Noncompetitive mGlu5 Receptor Antagonist with Inverse Agonist Activity Journal of Pharmacology and Experimental Therapeutics ·Richard H. Porter, Georg Jaeschke, Will Spooren, Theresa M. Ballard, Bernd Büttelmann, Sabine Kolczewski, Jens‐Uwe Peters, Eric Prinssen, Jürgen Wichmann, Eric Vieira, Andreas Mühlemann, S. Gatti, Vincent Mutel, Pari Malherbe	2005	246
3	A combined marble burying–locomotor activity test in mice: A practical screening test with sensitivity to different classes of anxiolytics and antidepressants European Journal of Pharmacology ·Laurent B. Nicolas, Yeter Kolb, Eric Prinssen	2006	191
4	RO4938581, a novel cognitive enhancer acting at GABAA α5 subunit-containing receptors Psychopharmacology ·Theresa M. Ballard, Frédéric Knoflach, Eric Prinssen, Edilio Borroni, Jeffrey A. Vivian, Jennifer Basile, Rodolfo Gasser, Jean‐Luc Moreau, Joseph G. Wettstein, Bernd Buettelmann, Henner Knust, Andrew W. Thomas, Gerhard Trube, Maria‐Clemencia Hernandez	2008	129
5	Assessment of Neuropsychiatric Adverse Events in Influenza Patients Treated with Oseltamivir Drug Safety ·Stephen Toovey, Craig R. Rayner, Eric Prinssen, Tom Chu, Barbara Donner, Bharat Thakrar, Regina Dutkowski, Gerhard Hoffmann, Alexander Breidenbach, Lothar Lindemann, Ellen Carey, Lauren Boak, Ronald Gieschke, Susan T. Sacks, Jonathan Solsky, Ian Small, David Reddy	2008	126
6	Zebrafish behavioral profiling identifies multitarget antipsychotic-like compounds Nature Chemical Biology ·Giancarlo N. Bruni, Andrew J. Rennekamp, Andrea Velenich, Matthew N. McCarroll, Leo Gendelev, Ethan Fertsch, Jack C. Taylor, Parth Lakhani, Dennis Lensen, Tama Evron, Paul J. Lorello, Xi-Ping Huang, Sabine Kolczewski, Galen Carey, Barbara J. Caldarone, Eric Prinssen, Bryan L. Roth, Michael J. Keiser, Randall T. Peterson, David Kokel	2016	111
7	The effect of the mGlu5 receptor antagonist MPEP in rodent tests of anxiety and cognition: a comparison Psychopharmacology ·Theresa M. Ballard, Marie L. Woolley, Eric Prinssen, Jörg Huwyler, Richard H. Porter, Will Spooren	2005	95
8	CTEP: A Novel, Potent, Long-Acting, and Orally Bioavailable Metabotropic Glutamate Receptor 5 Inhibitor Journal of Pharmacology and Experimental Therapeutics ·Lothar Lindemann, Georg Jaeschke, Aubin Michalon, Eric Vieira, Michael Honer, Will Spooren, Richard H. Porter, Thomas Härtung, Sabine Kolczewski, Bernd Büttelmann, Christophe Flament, Catherine Diener, Christophe Fischer, S. Gatti, Eric Prinssen, Neil Parrott, Gerhard Hoffmann, Joseph G. Wettstein	2011	91
9	Development of a Physiologically Based Model for Oseltamivir and Simulation of Pharmacokinetics in Neonates and Infants Clinical Pharmacokinetics ·Neil Parrott, Brian E. Davies, Gerhard Hoffmann, Annette Koerner, Thierry Lavé, Eric Prinssen, Elizabeth Theogaraj, Thomas P. Singer	2011	87
10	Behavioral Effects of a Synthetic Agonist Selective for Nociceptin/Orphanin FQ Peptide Receptors in Monkeys Neuropsychopharmacology ·Mei‐Chuan Ko, James H. Woods, William E. Fantegrossi, Chad M. Galuska, Jürgen Wichmann, Eric Prinssen	2009	80
11	Sembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer’s Disease Journal of Pharmacology and Experimental Therapeutics ·Edilio Borroni, Bernd Bohrmann, Fiona Grueninger, Eric Prinssen, Stephane Navé, Hansruedi Loetscher, Shankar J. Chinta, Subramanian Rajagopalan, Anand Rane, Almas Siddiqui, Bart Ellenbroek, Juerg Messer, Axel Pähler, Julie K. Andersen, R. Wyler, Andrea M. Cesura	2017	75
12	5-HT1A receptor activation and anti-cataleptic effects: high-efficacy agonists maximally inhibit haloperidol-induced catalepsy European Journal of Pharmacology ·Eric Prinssen, Françis C. Colpaert, Wouter Koek	2002	74
13	Evolution of a maternal immune activation (mIA) model in rats: Early developmental effects Brain Behavior and Immunity ·Katie N. Murray, Michelle E. Edye, Maurizio Manca, Anthony C. Vernon, Joanna M. Oladipo, Victoria Fasolino, Michael Harte, Varsha Mason, Ben Grayson, Patrick McHugh, Irène Knuesel, Eric Prinssen, Reinmar Hager, Joanna C. Neill	2018	63
14	Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets Nature Reviews Drug Discovery ·Anton Bespalov, Thomas Steckler, Bruce M. Altevogt, Elena Koustova, Phil Skolnick, Daniel R. Deaver, Mark J. Millan, Jesper F. Bastlund, Darı́o Doller, Jeffrey M. Witkin, Paul Moser, Patricio O’Donnell, Ulrich Ebert, Mark A. Geyer, Eric Prinssen, Theresa M. Ballard, Malcolm Macleod	2016	56
15	Surge in Expression of Carboxylesterase 1 During the Post-neonatal Stage Enables a Rapid Gain of the Capacity to Activate the Anti-influenza Prodrug Oseltamivir The Journal of Infectious Diseases ·Deshi Shi, Dongfang Yang, Eric Prinssen, Brian E. Davies, Bingfang Yan	2011	50
16	Combined antagonism of adrenoceptors and dopamine and 5-HT receptors underlies the atypical profile of clozapine European Journal of Pharmacology ·Eric Prinssen, Bart Ellenbroek, Alexander R. Cools	1994	39
17	Social approach–avoidance behavior of a high-anxiety strain of rats: effects of benzodiazepine receptor ligands Psychopharmacology ·Laurent B. Nicolas, Eric Prinssen	2005	39
18	Pharmacological profiles in rats of novel antipsychotics with combined dopamine D2/serotonin 5-HT1A activity: comparison with typical and atypical conventional antipsychotics Behavioural Pharmacology ·Laurent Bardin, Agnès L. Auclair, Mark S. Kleven, Eric Prinssen, Wouter Koek, Adrian Newman‐Tancredi, Ronan Depoortère	2007	38
19	The Role of Serotonin Receptor Subtypes in the Behavioural Effects of Neuroleptic Drugs. A Paw Test Study in Rats European Journal of Neuroscience ·Bart Ellenbroek, Eric Prinssen, Alexander R. Cools	1994	34
20	The great barrier belief: The blood–brain barrier and considerations for juvenile toxicity studies Reproductive Toxicology ·Georg Schmitt, Neil Parrott, Eric Prinssen, Paul Barrow	2017	32

About Eric Prinssen

Eric Prinssen is a scholar working on Biological Psychiatry, Cellular and Molecular Neuroscience, Behavioral Neuroscience, Sensory Systems and Psychiatry and Mental health, having authored 60 papers that have together received 2.8k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (29 papers), Neurotransmitter Receptor Influence on Behavior (16 papers), Neuroscience and Neuropharmacology Research (15 papers), Neuropeptides and Animal Physiology (11 papers), Influenza Virus Research Studies (11 papers), Pharmacological Receptor Mechanisms and Effects (9 papers), Tryptophan and brain disorders (7 papers) and Schizophrenia research and treatment (7 papers). The work is most often cited by research in Biological Psychiatry (374 citations), Behavioral Neuroscience (246 citations), Cellular and Molecular Neuroscience (1.2k citations), Neurology (235 citations) and Developmental Neuroscience (87 citations). Eric Prinssen has collaborated with scholars based in Switzerland, United States and France. Frequent co-authors include Laurent B. Nicolas, Stephen Toovey, Irène Knuesel, Markus Britschgi, Scott Schobel, Michael Bodmer, Jessica A. Hellings, Laurie Chicha, Wouter Koek and Will Spooren. Their work appears in journals such as European Journal of Pharmacology, Psychopharmacology, Bioorganic & Medicinal Chemistry Letters, Basic & Clinical Pharmacology & Toxicology and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact